Código QR (código de barras bidimensional)

Systemic AL (λ) Amyloidosis Discovered After Neoadjuvant Pembrolizumab‐Based Chemoimmunotherapy for Resectable NSCLC: Case Report

ABSTRACT Systemic AL amyloidosis is rarely reported in temporal association with immune checkpoint inhibitor use. We report a 69‐year‐old man with resectable stage IIB right upper lobe lung adenocarcinoma who received neoadjuvant pembrolizumab, carboplatin, and pemetrexed followed by robotic‐assiste...

Fuld beskrivelse

Na minha lista:
Principais autores: Weijie Ma, Dana M. Ferrari‐Light, Liang Lu
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2026-04-01
Serier:Respirology Case Reports
Fag:
AL amyloidosis
immune checkpoint inhibitor
lung adenocarcinoma
neoadjuvant immunotherapy
Online adgang:https://doi.org/10.1002/rcr2.70586
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker